Administered via a once-daily transdermal patch.
Here are the most exciting drugs in the pipeline right now.
This is the eighth indication approved for Xarelto.
Make a statement when you customize the editorial content with a full color reprint including an enhanced cover, your company logo, and a print ad.
Afamelanotide released through subcutaneous implant.
Injection for leading cause of severe vision loss and legal blindness.
Drug is the only respiratory therapy that can be given at home every 8 weeks.
First new treatment of its kind in over 20 years.
New HIV prevention drug not indicated for women.
For granulomatosis with microscopic polyangiitis in children.